Respiratory Drugs- HIV Flashcards
Enfuvirtide
Fusion inhibitor
Fosamprenavir
Protease inhibitor
Tipranavir
Protease inhibitor
Metabolism of etravirine
Inducer of 3A4
Inhibitor of 2C9 and 2C19
Adverse effects of Zidovudine
Blood issues as macrocytic anemia and neutropenia
Adverse effects of efavirenz
CNS issues such as drowsiness and dizziness
Darunavir
Protease inhibitor
Adverse effects of darunavir
Sulfa allergies
What is required with elvitegravir
Booster with cobicistat
Zanamivir
Anti-influenza
Nevirapine
non-NRTI in pregnant mothers and to the neonate
What must darunavir be coadministered with
Ritonavir or cobicistat
Protease inhibitor for pregnant women
Atazanavir
Darunavir
MOA of entry inhibitors
Binds to CCR5 to prevent the entry
Metabolism of elvitegravir
CYP3A4
Delaviridine
non-NRTI
When is lopinavir used
Combinationn with ritonavir as a booster
-In pregnant women
Peramivir
Anti-influenza
Benfits of enfuvirtide
None drug drug interactions
Efavirenz
non-NRTI
Adverse effects of Fosamprenavir
Sulfa allergies
headache, neausea, diarrhea
Oseltamivir
Anti-influenza
Fosamprenavir
Protease inhibitor
MOA or protease inhibitors
Blocks protease that allows mature vision
Etravirine
Diarylpyrimidine non-NRTI
Didanosine
Deoxyadenoxine NRTIs
Adverse effects and resistant mechanism of al NRTIs
Mito toxicity
Point mutations in RT
MOA for Peranivir
Inhibits neuromenidase
What are the boosting agents and how do they work
Ritonavir
• Cobicistat
Affect CYP3A4
Maraviroc
Entry inhibitors
When is dolutegravir used
Treatment of naive pts with:
1- tenofovir/emtricitabine or
2-abacavir/lamivudine
Metabosism of protease inhibitors
CYP3A4
Metabolism of Efavirenz
CYP3A4 and 2B6
Metabolism of delavirdine
CYP3A4 and 2D6
Atazanavir
Protease inhibitor
Nelfinavir
Protease inhibitor
What is commonly used as a booster with Saqyunavir
Ritonavir to reduce toxicities
MOA of non-NRTI
Binds directly to RT resulting in allosteric inhibiton
MOA of integrase strand transfer inhibitor
Prevents integration into the host DNA
Ritonavir
Protease inhibitor
MOA for oseltamivir
Inhibits neuormenidase
Stavudine
Thymidine NRTIs
Zidovudine
Deoxythymidine NRTIs
Adverse affects of delavirdine
Skin rash and pregnancy effects
Adverse effects of protease inhibitors
GI intolerance
-lipid changes such as hyperglycemia, hyperlipidemia, fat redistribution, cushing like symptoms
What other condition is treated with emtricitabine and lamivudine
HBV
Rilpivirine
Diarylpyrimidine non-NRTI in pregnanct women
Lopinavir
Protease inhibitor
Adverse effects of Nelfinavir
Gas
MOA for Zanamivir
Inhibits neuromenidase
Indinavir
Protease inhibitor
Adverse effects of tiranavir
Sulfa allergy
Maculopapular rash
D/N/V
Adverse effects of stavudine
Sensory neuropathy especially in immunosuppression pt
Emtricitabine
Fluoridated version of lamivudine NRTIs
Dolutegravir
Integrase strand transfer inhibitor
Adverse effects of Indinavir
Unconjugated hyperbilirubinemia and nephrolithisasis (must drung water to prevent)
What mutation would grant resistance against maraviroc
V3 loop of gp120
Abacavir
Guanosine NRTIs
Adverse effects of emtricitabine
Hyperpigmentation if palms and soles
MOA of fusion inhibitors
Binds to gp41 and prevents binding and fusion with cell membrane
Saquinavir
Protease inhibitor
When is ritonavir used
As a booster due to its inhibition of 3A4 and GI issues
Tenofovir
Acyclic adenosine NRTIs
Lamivudine
Cytosine NRTIs
When is raltegravir recommended
Naive persions with HAART and Pregnancy
Elvitegravir
Integratse strand transfer inhibitor
Pharmokinetics and adverse effects of enfuvirtide
SubQ bid, reactions at injection site
Raltegravir
Integrase strand transfer inhibitor
When is Tiranavir
When resistance to other Protease inhibitors
Adverse effects of didanosine
Pancreatitis (especially with alcohol abuse, hyperTAGs)
Retinal changes and optic neuritis